Precision Medicine

Medidata’s cloud-based services help with the development of therapeutic innovations and clinical operations performance for pharmaceutical companies, biotechnology firms and others.

It will be the first and most comprehensive data hub in multiple myeloma designed to speed the delivery of precision-based treatment to every patient.

The new facility, dedicated to technology-enabled health research, should be shovel ready by next year and under construction between 2021-2022, say university officials.

One company is working on cutting-edge technology that could change the way providers treat neurological diseases.

The work aims to personalize cancer care using a patient’s DNA.

[Correction: An earlier version of this article misstated that Bumrungrad launched the Foundation One CDx panel.

Australia’s national science agency CSIRO and GenesisCare, one of Australia’s largest cancer care providers, today announced a A$5.

Recursion releases more than 300 gigabytes of data it hopes will be a "playground" for innovative new machine learning applications.

Pinnacle Ventures has launched a pharmacogenomics programme to enable genetic testing to drive personalised prescribing decisions.

Earlier this week, the Western Australia (WA) Government announced the establishment of a new Ministerial Council that will advise the State Government on opportunities to further develop and support precision health advances.